BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2336 related articles for article (PubMed ID: 12791168)

  • 1. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
    Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
    Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's disease and ulcerative colitis: morbidity and mortality.
    Rod Riley
    Health Rep; 1990; 2(4):343-59. PubMed ID: 2101290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey.
    Haapamäki J; Turunen U; Roine RP; Färkkilä MA; Arkkila PE
    Scand J Gastroenterol; 2008; 43(7):821-30. PubMed ID: 18584521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric inflammatory bowel disease in New Zealand.
    Yap J; Wesley A; Mouat S; Chin S
    N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    Am J Gastroenterol; 2003 Jul; 98(7):1563-8. PubMed ID: 12873578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
    Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
    Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic inflammatory bowel disease in children. An epidemiological study from eastern Denmark 1998-2000].
    Urne FU; Paerregaard A
    Ugeskr Laeger; 2002 Dec; 164(49):5810-4. PubMed ID: 12523226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prevalence of inflammatory bowel diseases in gastroenterology primary care setting.
    Tursi A; Elisei W; Picchio M
    Eur J Intern Med; 2013 Dec; 24(8):852-6. PubMed ID: 23867759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey.
    Longobardi T; Jacobs P; Wu L; Bernstein CN
    Am J Gastroenterol; 2003 Apr; 98(4):844-9. PubMed ID: 12738466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 117.